|
Thomas, Joyce N (2007) Evidence-based practice can reduce child abuse in low-income communities. J Spec Pediatr Nurs 12:294-6
|
|
Dickerson, Erin B; Fosmire, Susan; Padilla, Marcia L et al. (2002) Potential to target dysregulated interleukin-2 receptor expression in canine lymphoid and hematopoietic malignancies as a model for human cancer. J Immunother 25:36-45
|
|
Soergel, S A; MacEwen, E G; Vail, D M et al. (1999) The immunotherapeutic potential of activated canine alveolar macrophages and antitumor monoclonal antibodies in metastatic canine melanoma. J Immunother 22:443-53
|
|
Phillips, B S; Padilla, M L; Dickerson, E B et al. (1999) Immunostimulatory effects of human recombinant interleukin-12 on peripheral blood mononuclear cells from normal dogs. Vet Immunol Immunopathol 70:189-201
|
|
Helfand, S C; Dickerson, E B; Munson, K L et al. (1999) GD3 ganglioside antibody augments tumoricidal capacity of canine blood mononuclear cells by induction of interleukin 12. Cancer Res 59:3119-27
|
|
London, C A; Kisseberth, W C; Galli, S J et al. (1996) Expression of stem cell factor receptor (c-kit) by the malignant mast cells from spontaneous canine mast cell tumours. J Comp Pathol 115:399-414
|
|
Helfand, S C; Hank, J A; Gan, J et al. (1996) Lysis of human tumor cell lines by canine complement plus monoclonal antiganglioside antibodies or natural canine xenoantibodies. Cell Immunol 167:99-107
|
|
Helfand, S C; Modiano, J F; Moore, P F et al. (1995) Functional interleukin-2 receptors are expressed on natural killer-like leukemic cells from a dog with cutaneous lymphoma. Blood 86:636-45
|
